Lisinopril And Hydrochlorothiazide Tablet
Product Images NDC 71335-0862

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lisinopril And Hydrochlorothiazide (NDC 71335-0862). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula Of Lisinopril (Image 1)

Chemical structure of Lisinopril and Hydrochlorothiazide depicted, showing molecular bonds and arrangement including phenyl ring, peptide linkages, and hydrated form with two water molecules (dihydrate).*

FDA Label Image

Structural Formula Of Hydrochlorothiazide (Image 2)

Chemical structure diagram showing a sulfonamide compound with a chlorine-substituted benzene ring and a bicyclic amine sulfonamide structure. This likely represents the active ingredient related to the product Lisinopril and Hydrochlorothiazide.*

FDA Label Image

Label (Lbl713350862)

Label for Lisinopril HCTZ 20 mg/12.5 mg tablets packaged by Bryant Ranch Prepack, featuring comparison to Zestoretic 20/12.5 mg tablet by Watson Pharma Private Limited. The label also includes storage instructions to keep the product at room temperature between 20°-25°C (68°-77°F), and displays the NDC number 7133508621 along with a barcode and lot number 1523487.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.